BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38114477)

  • 1. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
    Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
    Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions.
    Liu J; Dai L; Wang Q; Li C; Liu Z; Gong T; Xu H; Jia Z; Sun W; Wang X; Lu M; Shang T; Zhao N; Cai J; Li Z; Chen H; Su J; Liu Z
    Nat Commun; 2024 May; 15(1):3700. PubMed ID: 38697989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
    Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
    Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
    Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
    ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nasrollahzadeh D; Roshandel G; Delhomme TM; Avogbe PH; Foll M; Saidi F; Poustchi H; Sotoudeh M; Malekzadeh R; Brennan P; Mckay J; Hainaut P; Abedi-Ardekani B
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer.
    Wang S; Meng F; Li M; Bao H; Chen X; Zhu M; Liu R; Xu X; Yang S; Wu X; Shao Y; Xu L; Yin R
    Am J Respir Crit Care Med; 2023 May; 207(9):1203-1213. PubMed ID: 36346614
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.
    Li K; Lin Y; Zhou Y; Xiong X; Wang L; Li J; Zhou F; Guo Y; Chen S; Chen Y; Tang H; Qiu X; Cai S; Zhang D; Bremer E; Jim Yeung SC; Zhang H
    Gastroenterology; 2023 Oct; 165(4):932-945.e9. PubMed ID: 37399999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients.
    Kahng DH; Kim GH; Park SJ; Kim S; Lee MW; Lee BE; I H
    J Korean Med Sci; 2022 Jun; 37(24):e197. PubMed ID: 35726148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional landscape and diagnostic potential of long non-coding RNAs in esophageal squamous cell carcinoma.
    Zhou M; Bao S; Gong T; Wang Q; Sun J; Li J; Lu M; Sun W; Su J; Chen H; Liu Z
    Nat Commun; 2023 Jun; 14(1):3799. PubMed ID: 37365153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients.
    Meng P; Wei J; Geng Y; Chen S; Terpstra MM; Huang Q; Zhang Q; Su Z; Yu W; Su M; Kok K; van den Berg A; Gu J
    BMC Cancer; 2019 Aug; 19(1):818. PubMed ID: 31429737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Highly Sensitive and Specific Non-Invasive Test through Genome-Wide 5-Hydroxymethylation Mapping for Early Detection of Lung Cancer.
    Ren Y; Zhang Z; She Y; He Y; Li D; Shi Y; He C; Yang Y; Zhang W; Chen C
    Small Methods; 2024 Mar; 8(3):e2300747. PubMed ID: 37990399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Hsieh CC; Hsu HS; Chang SC; Chen YJ
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
    Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
    Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.